We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
-15.46%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$255M
AUM Growth
-$25.5M
Cap. Flow
-$5.11M
Cap. Flow %
-2.01%
Top 10 Hldgs %
61.19%
Holding
47
New
14
Increased
12
Reduced
6
Closed
13

Top Buys

Rank Stock Value
1
XNPT
XENOPORT, INC.
XNPT
+$8.14M
2
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$7.97M
3
AVTA
Avantax, Inc. Common Stock
AVTA
+$7.55M
4
TBPH icon
Theravance Biopharma
TBPH
+$6.54M
5
TLRD
Tailored Brands, Inc.
TLRD
+$6.17M

Top Sells

Rank Stock Value
1
INVA icon
Innoviva
INVA
+$12.3M
2
ENR icon
Energizer
ENR
+$10.2M
3
JCP
J.C. Penney Company, Inc.
JCP
+$9.06M
4
FL
Foot Locker
FL
+$8.07M
5
THC icon
Tenet Healthcare
THC
+$7.64M

Sector Composition

Rank Sector Weight
1 Healthcare 37.91%
2 Miscellaneous 29.25%
3 Consumer Discretionary 12.21%
4 Consumer Staples 10.96%
5 Financials 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$812B
$57.5M 22.59%
280,000
+80,000
+40% +$15.6M
ATRS
2
DELISTED
Antares Pharma, Inc.
ATRS
$13.4M 5.26%
15,405,703
+2,165,703
+16% +$2.1M
VNDA icon
3
Vanda Pharmaceuticals
VNDA
$326M
$13.4M 5.25%
1,600,000
-30,000
-2% -$246K
XNPT
4
DELISTED
XENOPORT, INC.
XNPT
$12.8M 5.04%
2,846,000
+1,766,000
+164% +$8.14M
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
$11.4M 4.49%
1,688,000
+736,000
+77% +$6.06M
FRPT icon
6
Freshpet
FRPT
$3.3B
$10.1M 3.95%
1,372,000
-322,000
-19% -$2.25M
AVTA
7
DELISTED
Avantax, Inc. Common Stock
AVTA
$9.85M 3.86%
1,908,000
+1,074,000
+129% +$7.55M
ACOR
8
DELISTED
Acorda Therapeutics
ACOR
$9.47M 3.72%
2,983
+1,150
+63% +$4.77M
HAIN icon
9
Hain Celestial
HAIN
$62.3M
$9.16M 3.6%
224,000
– –
BDSI
10
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8.76M 3.44%
2,712,000
+92,000
+4% +$340K
TVTY
11
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$8.48M 3.33%
840,000
+120,000
+17% +$1.35M
TBPH icon
12
Theravance Biopharma
TBPH
$887M
$7.52M 2.95%
+400,000
New +$6.54M
TLRD
13
DELISTED
Tailored Brands, Inc.
TLRD
$7.16M 2.81%
+400,000
New +$6.17M
LVS icon
14
Las Vegas Sands
LVS
$28.7B
$6.41M 2.52%
+124,000
New +$5.68M
SGYP
15
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$6.07M 2.38%
+2,200,000
New +$7.97M
ARRY
16
DELISTED
Array Biopharma Inc
ARRY
$5.9M 2.32%
+2,000,000
New +$5.99M
KATE
17
DELISTED
Kate Spade & Company
KATE
$5.72M 2.24%
224,000
-116,000
-34% -$2.28M
AEGR
18
DELISTED
Aegerion Pharmaceuticals
AEGR
$5.54M 2.18%
1,498,000
+296,000
+25% +$1.83M
LEAF
19
DELISTED
Leaf Group Ltd.
LEAF
$5.48M 2.15%
1,096,000
-60,000
-5% -$299K
NOMD icon
20
Nomad Foods
NOMD
$1.6B
$5.12M 2.01%
+568,000
New +$4.79M
BWLD
21
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$4.74M 1.86%
+32,000
New +$4.89M
TTWO icon
22
Take-Two Interactive
TTWO
$40.3B
$4.67M 1.83%
+124,000
New +$4.29M
PLAY icon
23
Dave & Buster's
PLAY
$306M
$3.8M 1.49%
+98,000
New +$3.58M
DECK icon
24
Deckers Outdoor
DECK
$11.4B
$3.6M 1.41%
360,000
-624,000
-63% -$5.39M
CHEF icon
25
Chefs' Warehouse
CHEF
$4.57B
$3.57M 1.4%
+176,000
New +$2.9M
1
2

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Armistice Capital held 47 positions worth $255M, down 9.1% from $280M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital's Q1 2016 filing shows 14 new, 12 increased, 6 reduced and 13 closed positions. Its largest new stake was Synergy Pharmaceuticals, Inc Common Stock: 2,200,000 shares worth $6.07M. The largest sale was Innoviva, an estimated $12.3M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 46% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

  • Armistice Capital's largest Q1 2016 buy was Synergy Pharmaceuticals, Inc Common Stock: 2,200,000 shares worth $6.07M.
  • Armistice Capital added most to XENOPORT, INC. in Q1 2016, an estimated $8.14M increase.
  • Armistice Capital's biggest Q1 2016 reduction was Spectranetics Corp, cutting an estimated $5.73M.
  • Armistice Capital fully exited Innoviva in Q1 2016, selling an estimated $12.3M.
  • Armistice Capital's ten largest holdings make up 61% of its $255M portfolio in Q1 2016.
  • Armistice Capital opened 14 new positions and closed 13 in Q1 2016.
  • Armistice Capital's portfolio value fell 9.1% quarter-over-quarter to $255M.

Based on Armistice Capital's 13F filing for Q1 2016, filed 16 May 2016.